The iCARE Dengue NS1/Itg/IgM Combo Rapid Test Kit is intended for qualitative testing of the Dengue NS1 antigen and IgG/IgM antibodies. It is the recommended diagnostic test for patients with suspected Dengue disease.

iCARE Dengue NS1/IgM Combo Rapid Test Kit

The iCARE Dengue NS1/Igg/M Combo Rapid Test Kit is an immunochromatographic assay that detects the NS1 antigen of dengue virus and the differential IgG/IgM antibody responses in human specimens. The kit uses two test devices and is designed to detect the dengue virus in a specimen in just one step. The results are accurate within a few hours and may be used to make decisions on the care of a patient.

The NS1 RDT kit can detect DENV antibodies within a day or two of the onset of symptoms. However, detection of anti-DENV IgM antibodies is not possible within the acute phase of the infection. It takes approximately 3-5 days to detect anti-DENV IgM antibodies, and 10-14 days to detect anti-DENV IgG antibodies. Using the iCARE Dengue NS1/IgeG/IgM Combo Rapid Test kit, results can be obtained within 15 minutes and without the use of special laboratory equipment.

Dengue RT-PCR

The iCARE Dengue RT-PCR Kit uses a fluorogenic detection system. It is effective in detecting the four serotypes of dengue virus. It has universal and type specific detection methods, and has low cross-reactivity. In addition, it is fast, easy to use, and reliable.

The iCARE Dengue RT-PCR Kit contains primers and probes. The reagents contain Taqman probes that bind to target DNA between the unlabeled primers. The dengue-specific primer is labeled BHQ-1, which quenches the fluorescent dye signal. The kit includes 12 eight-well strips and four probe reporter dyes.

The iCARE Dengue RT-PCR Kit can be used to confirm the diagnosis of dengue. It detects dengue with a high degree of sensitivity. The kit can detect DENV-1, DENV-3, and DENV-4. The results are accurate and fast, and can be used for patient management.

If you’re worried about getting HIV, you may want to consider the iCARE HIV 1&2 Tri-Line Rapid Test. This oral HIV screening test is a one-step immunoassay that determines the presence of antibodies to HIV-1 and HIV-2 in an oral swab. It’s an excellent option for both in-office and home HIV testing.

iCARE HIV 1/2 Oral Rapid Screen Test

The iCARE HIV 1/2 Oral Rapid Screen test is designed to identify antibodies to HIV in oral fluid. This test is highly accurate and can detect both HIV-1 and HIV-2. The test is available for both hospital and at-home use. The test uses a double antibody sandwich method. The sample is mixed with four drops of antibody dye conjugate and the results are displayed on a color line. The test can be repeated if a positive result is identified.

The iCARE HIV 1/2 Oral Rapid Screen test uses an immunoassay to detect antibodies to HIV-1/2 in oral swabs. HIV-1/2 antibodies are bound to a binding protein on a membrane, which is precoated onto the test membrane. The oral swab specimen reacts with colloidal gold reagents labelled with HIV-1/2-specific antigens. If a pink colour band is present in the test, there are antibodies to the virus, while a negative result means there are no antibodies.

The iCARE HIV 1/2 Oral Rapid Screen test has an accuracy rate of 99%. The test is accurate and fast. Results are available in less than 10 minutes. HIV is a virus that breaks down the immune system and causes acquired immunodeficiency syndrome. If the infection becomes advanced, it can lead to AIDS. Therefore, it is important to get tested for HIV before it causes any serious disease.

Rapid HIV tests are a key tool in the 90-90-90 target set by the World Health Organization. These tests are widely available from online vendors. In order to make sure that they provide accurate results, rapid tests need to undergo quality assurance testing. Researchers tested nine rapid HIV tests on a large panel of HIV-positive and HIV-negative samples. All the tests were validated against an established methodology, using a whole blood reconstitution protocol.

Rapid HIV tests can detect HIV-1 and HIV-2 in oral fluids. The American Red Cross uses rapid oral HIV testing to screen blood donors. The test can detect HIV-1 and HIV-2 antibodies within three to six months of infection. In fact, most HIV-infected individuals develop antibodies to the virus in their blood within three to six months after infection.

Rapid HIV tests have revolutionized HIV testing. Many clinics, emergency rooms, and temporary screening sites offer the test to help identify HIV exposure. They are also useful for HIV testing among pregnant women and people who are at risk of HIV infection. Using a rapid test is an excellent way to prevent HIV infection and save lives.

iCARE HIV 1/2 Oral Rapid Screen test is a convenient alternative to a conventional HIV test. It provides results in 15 minutes or less. Traditional HIV tests require oral fluid and blood samples, which are typically sent to a lab for further analysis. The rapid test allows for screening more people in less time and with virtually no delay.

The iCARE Hepatitis B Vaccines Rapid Test Kit is a rapid screening test for detecting Hepatitis B virus infections. It produces the results within 10 minutes. The kit also detects HIV 1 and 2 viruses. It is an easy to use kit and is available at most drugstores.

iCARE Hepatitis B Virus Rapid Test Kit

The iCARE Hepatitis B – Virus Rapid Test Kit allows you to quickly and easily detect the presence of Hepatitis B virus in your blood. It uses an antigen test that is safe to use. The test contains harmless substances. In addition, the results are available in just 10 minutes.

Hepatitis B is a viral infection of the liver that is transmitted through body fluids. In the early stages, this infection causes liver inflammation, which can progress to cirrhosis. Other symptoms of hepatitis B include fatigue, nausea, and dark urine. The iCARE Hepatitis B Virus Rapid Test Kit is the only test available today that will confirm whether you have the infection. It is certified to the highest quality standards by the ISO 13485, the most widely recognized Medical Device Standard, and exceeds FDA and other regulatory guidelines.

The iCARE Hepatitis B – Virus Rapid Test Kit will provide positive or negative results for both types of hepatitis B infection. Since the infection is chronic and can be chronic, a positive test result should be reviewed with a physician to ensure it is not a complication of another condition. There are more expensive tests for the diagnosis of hepatitis B, and only a physician can order them.

While the iCARE Hepatitis B – Virus Rapid Test Kit is a convenient and affordable way to screen for the virus, the quality of the results may not be the highest. Several studies have demonstrated that the rapid tests for HBV are prone to false negative results. These studies highlight the need for quality assurance of rapid testing devices and other medical devices.

iCARE HIV 1&2 Rapid Screen Test

The iCARE HIV 1&2 Rapid Screen Testing Kit allows you to check for HIV in 10 minutes or less. This test kit is used to identify the presence of antibodies to HIV in plasma, serum, or whole blood. In addition to giving you an accurate result, this kit is fast and easy to use.

To provide the most accurate results, this test must meet specific criteria. It should have high sensitivity and specificity. These characteristics are important to prevent missed diagnoses due to unacceptable false-positive results. Although it may seem easy to guarantee a high sensitivity and specificity, there are some factors that can affect the test’s performance in real-life surveillance. For instance, the clinical status of the patient, the genetic makeup of the HIV strain responsible for the infection, and the population may affect the test’s sensitivity.

The iCARE HIV 1&2 Rapid Screen test kit uses a chromatographic, immune-chromatographic method for qualitative detection of HIV antibodies. This test kit is used to check the level of anti-body against any of the four HIV isotypes and subtype O in whole blood samples. The kit has a 24-month shelf life, and is good for up to three years after being used.

The iCARE HIV 1&2 Rapid Screen test is a highly sensitive test. It can detect the p24Ag (HIV protein) line with a specific line. It is ideal for use in community-based settings and as a primary HIV test.

The iCARE Syphilis Rapid Test can diagnose whether a person is infected with the syphilis bacterium. The test requires a finger-prick blood sample. The testing company then connects positive test results to a physician.

iCARE Syphilis Rapid Test

The iCARE System offers a variety of home tests for several different infections, including syphilis. All tests require a finger-prick blood or urine sample, and results are provided within two to five days. The company provides prepaid shipping labels.

Traditional tests require that samples be collected by a healthcare provider, which may be difficult for someone without experience. In addition, a home test can lead to a false positive if the person is not familiar with the proper way to collect the sample. This is why a systematic review comparing the accuracy of self-collected samples collected by a healthcare professional found that the latter was more accurate, but still had some margin of error. The home test allows for convenient testing and payment up front.

uses CLIA-certified laboratories to analyze the sample and connect it with your physician if the results are positive. This at-home test is affordable and easy to use. All you need to do is collect a finger-prick blood sample. The testing company will send it to a CLIA-certified laboratory. A positive test will show that the bacterium responsible for the infection is present in the sample.

iCARE Syphilis Rapid Test

The iCARE Syphilis rapid test can provide you with an accurate diagnosis in 15 minutes. The test checks for antibodies produced in response to the TP bacterium. The test is safe to use and the antigens used are non-infectious. However, the results of a positive test should be confirmed by a physician.

The rapid test can detect multiple STIs. Its sensitivity and specificity are exceptional. However, it is important to note that some people may not receive treatment. Therefore, you should get tested regularly to reduce your chances of contracting an STD. The frequency of testing will depend on your lifestyle, sexual practices, and the type of sexual activity you are involved in.

If you get a positive test, you should seek medical treatment as soon as possible. You should also consider retesting with another type of syphilis test if you are uncertain. will retest you for free if you are not sure if you have the disease or not. This will reduce the chances of receiving false positives.

iCARE Syphilis Rapid Test

The Syphilis Rapid Test is an affordable and easy way to check whether you are infected with syphilis. The test works by detecting antibodies to the syphilis bacteria. It is important to note that this test cannot differentiate between an active infection and an infection that has been successfully treated. It should be used in conjunction with a physician’s consultation to determine if you are positive for syphilis.

The Syphilis Rapid Test is available in single-test and package-test options. Individual kits test for syphilis and ten other STDs, including Chlamydia, Trichomoniasis, Herpes 2, and HIV I/II. The website also allows you to choose an STD testing strategy that is customized to your specific needs. The test uses FDA-cleared components and is performed in an accredited, CLIA-certified laboratory.

The Syphilis Rapid Test is available for purchase online, and includes free two-day shipping. Using the test is simple and quick: you simply need to collect a finger-prick sample of your blood. The testing company sends the sample to a CLIA-certified laboratory, and your results are usually delivered in two to five days. Depending on the severity of your case, you may need further testing by your physician. The results are posted in a secure account online.

The iCARE Gonorrhea rapid test kit can be used to test for the presence of the gonorrhea bacteria in your body. It is safe to use because the substances contained in the kit are non-infectious. The kit also contains instructions on how to use the test.

Gonorrhea Rapid Test Cassette

The Gonorrhoea Rapid Test Cassette is a rapid immunochromatographic test used to diagnose gonorrhea. The test uses a swab and a single PCR reaction to detect antigens from Neisseria gonorrhoeae. The test is intended for professional use and is CE-marked.

The test kit provides results within 10 minutes. It is based on a ferrocene-antimicrobial peptide modified biosensor. It can detect both pathogenic and non-pathogenic E. coliO157:H7.

iCARE’s at-home gonorrhea testing kits are affordable and convenient. They require a urine sample or a swab from the genitals or throat. The results are available online in three to four business days.

The iCARE Gonorrhea rapid test kit comes with detailed instructions for use. It is a convenient and affordable way to screen for gonorrhea and prevent reinfection. Taking gonorrhea early in its early stages reduces the risk of serious complications. It can also prevent the spread of infection to other sexual partners.

The Gonorrhea Rapid Test kit is a presumptive test for detection of Neisseria gonorrhoeae. The test is not conclusive unless it is accompanied by further tests such as cell culture. The results from the test should be interpreted by a physician who combines clinical symptoms and laboratory results to determine the condition.

The iCARE Dengue NS1 Rapid test kit has several advantages. Designed to detect acute infection with the dengue virus without providing information on serotype, it is sensitive and specific. The test can be used at airports and detect imported cases of the disease. It is able to detect the NS1 nonstructural protein of the virus.

Detects Imported Dengue Cases at Airports in Taiwan

A new rapid test for dengue virus (DENV) was developed to detect imported cases of the virus at airports in Taiwan. The kit, iCARE Dengue NS1 Rapid Testing Kit, has high sensitivity and specificity, making it an effective tool for the on-site detection of suspected dengue cases. The kit was successfully used to screen 850 patients suspected of having dengue fever and identified 22 positive cases of dengue.

Taiwan’s health authorities are working together to combat the dengue fever epidemic. The Ministry of Health and Welfare convened a meeting with health care professionals from Taian City and Kaohsiung City for a coordinated strategy to fight the mosquito-borne disease. One of the conclusions reached by the meeting was that the National Health Insurance will cover the cost of Dengue NS1 antigen tests starting mid-September.

The rapid test for dengue NS1 is a rapid immunochromatographic strip assay that detects dengue non-structural protein in human serum. This rapid test detects early cases of Dengue even before IgM or IgG antibodies are present.

Detects Acute Infection With Dengue Virus Without Providing Serotype Information

iCARE Dengue NS1 Rapid Testing Kit is a point-of-care diagnostic test for acute infection with dengue virus. It is an alternative to SD Bioline Dengue Duo and SD Bioline Dengue NS1 ELISA. These two RDTs use biosensors to detect dengue virus, and both require approximately the same amount of blood specimen. The differences between them are mainly in the sample load and test duration.

In dengue-endemic countries, where diagnostic laboratories are not available, patients must rely on clinical recognition and bedside tests to make a diagnosis. Compared to other tests, the NS1 strip exhibits high sensitivity and specificity in acute infection with dengue virus but has lower sensitivity in secondary infections. The results of these tests were not affected by differences in viral serotypes, which could make the test more useful in cases where a patient has been exposed to multiple dengue infections.

The iCARE Dengue NS1 Rapid Testing Kit detects acute infection with dengue virus with a NS1 antigen without providing serotype information. The test results are accurate, and the positive test results are considered reliable. The test is available as a commercial diagnostic kit. A few public health laboratories also use this test.

Contains Nonstructural Protein NS1 of Dengue Virus

The iCARE Dengue NS1 Rapid test kit contains nonstructural protein NS1 of the dengue virus, a biomarker of acute infection with the virus. The test indicates whether you have had recent exposure to the virus and whether you are at risk for severe disease if you are infected with dengue. This test should be used for diagnostic purposes only. The NS1 antigen overlaps with dengue virus viremia, and thus can be used as an early warning sign of infection.

NS1 may be involved in coagulation, which means that it can affect the blood. One study showed that NS1 inhibited the activation of prothrombin, resulting in a prolonged activated partial thromboplastin time. However, it is not known if NS1 is involved in thrombocytopenia, which is a complication of dengue infection. NS1 may also be involved in platelet aggregation and the destruction of platelets.

There are a few things to consider when using an iCARE Malaria P. falciparum Rapid Test Kit, from how accurate it is.

Molecular Detection of Low-density P. falciparum Infections

A novel malaria diagnostic test that combines ddPCR and qPCR has been developed by the iCARE company. This rapid test kit is a highly sensitive and specific method for the detection of parasite DNA in human blood samples. The kit is designed to identify the presence of P. falciparum parasite DNA in a range of samples.

The new test is more sensitive than previous rapid malaria diagnostic kits for detecting parasite DNA. It also allows for high-throughput detection of P. falciparum DNA in DBS. However, the method requires a dedicated PCR laboratory. In addition, it provides more accurate prevalence data. A full data set can be requested from M. Hetzel and colleagues.

The assay is highly sensitive and specific and detects tRNA positivity and hrp2 and hrp3 deletions. It is also sensitive enough to detect mixed infections between parasites with wild-type and hrp2 deletion. In a recent study, the assay was validated with samples from six countries. The results showed good performance. The study found that the assay was accurate across a wide range of parasite densities. The data showed that the RDT performed well. However, some of the field samples required repeated testing due to poor separation between the negative and positive droplets.

Accuracy of Rapid Diagnostic Tests for Malaria

Rapid diagnostic tests for malaria have a number of advantages. The tests detect malaria antigens in a small amount of blood without the use of a microscope and can provide a positive or negative result within 15 minutes. The tests can be used in endemic areas where microscopy is not a viable option.

Several tests have been developed to measure the accuracy of diagnosis of malaria. These include the Gazelle test, malaria specific polymerase chain reaction (PCR), and RDT. Each test has a range of sensitivity and specificity, which vary based on the type of infection and the goals of malaria control in a given region.

Accurate malaria diagnosis is crucial to improving case management and reducing associated morbidity and mortality. Accurate diagnosis is also important for epidemiological screening, informing malaria control strategies, and testing antimalarial drugs.

iCARE Malaria P. falciparum Rapid Test Kit

The cost of malaria rapid diagnostic tests (RDTs) is lower than the price of the drug malarial artemisinin. These tests can detect malaria parasites in peripheral blood. They use a finger or heel prick and provide results within 20 minutes. RDTs require no specialist services or infrastructure and are suitable for use in remote areas.

Malaria research is ongoing to improve the effectiveness of malaria diagnostic tools. Researchers have developed a real-time malaria diagnostic test called RealAmp. Researchers are now testing this real-time malaria diagnostic kit to determine its efficacy. They also hope the rapid test will improve the rate of detection of malaria in low-income areas.

It is recommended for use by healthcare workers in remote areas where malaria is prevalent. However, it should not be used for follow-up of malaria patients. Moreover, the results of RDTs should be interpreted cautiously. In case of doubt, the results of the test should be verified by a BFT. Furthermore, uncontrolled migratory flows might introduce new variants of Plasmodium and affect the test’s efficiency.

If you are concerned about malaria, you should use a rapid malaria test. There are several options available, including the  Malaria Pf/Pan Ag Rapid Test,  Dengue NS1 Antigen FP, and the iCare Malaria P. vivax Tri-line rapid test kit. It is also important to read the product insert before you begin the test.

iCare Malaria P. falciparum + P. vivax Tri-line Rapid Test Kit

This fast and convenient test kit detects Plasmodium falciparum and P. vivax parasites, both of which can cause malaria. It uses two specific soluble proteins, histidine-rich protein II and lactate dehydrogenase, to determine the presence of the parasite. This allows doctors and health workers to know if a person has malaria or not.

This rapid test kit is available only for whole blood specimens, and should be used for detection of the presence of Plasmodium spp. antigens. The results should be interpreted with care because this test cannot be used as a sole diagnosis of malaria infection.

Malaria Pf/Pan Ag Rapid Test

The Malaria P.f./Pan Rapid Test Cassette is a qualitative test for malaria that is performed from a whole blood specimen. The test can detect malaria parasites by detecting antigens found in Plasmodium spp., but should not be used as a primary diagnosis of malaria infection.

The Advantage Malaria Card uses the Sandwich principle to identify malaria parasites. It works by using colloidal gold conjugate, a nitrocellulose strip, and two specific soluble proteins, histidine-rich protein II and lactate dehydrogenase. These proteins can differentiate between the two strains of malaria.

Malaria NS1 Antigen FP

This rapid test kit allows you to easily detect malaria by detecting antibodies in the blood. The test uses highly specific antibodies to detect malaria antigens. However, it should not be used as a primary diagnostic test. You should consult a physician if you suspect that you have malaria or you suspect that you may have the disease.

This rapid test kit detects circulating malaria antigens in the red blood cells or whole blood. The malaria protozoan invades the red blood cells of human hosts and is one of the deadliest diseases. According to the World Health Organization (WHO), malaria affects approximately 300 million people worldwide and accounts for one million deaths each year. Sadly, most victims are children.

Dengue NS1 Antigen FP

The Dengue NS1 Antigen Rapid Test Cassette detects the dengue virus NS1 antigen in human serum or plasma samples. This test is designed for clinical use as a screening test for dengue virus infection. However, it should not be used as a definitive diagnosis. In such cases, alternative tests should be performed to confirm the results.

This rapid test kit is designed to detect the dengue NS1 antigen in human serum, plasma, and whole blood samples. It also detects the NS1 antigen in samples from patients with secondary infections. This makes the test more sensitive and reliable, and also increases the test’s value.

The iCARE HCG Rapid Test is a presumptive diagnosis of pregnancy that is 99 percent accurate. It detects hCG concentrations of at least 50 mIU/ml. However, you should remember that this test can produce misleading results. This is because hCG can be detectable for days or weeks after delivery, spontaneous abortion, or hCG injection. Other factors that could produce false results include ectopic pregnancy, ovarian cysts, menopause, and rare medical conditions. Hence, it is best to consult a physician before using this test.

iCARE HCG Rapid Test is 99 Per Cent Accurate

Using a home pregnancy test is the easiest way to confirm your pregnancy, whether you are early in your cycle or several weeks along. These tests use a dipstick, which reveals a result within a few minutes. You can expect to see either a plus or a minus sign, a single line, or even a few words.

A number of home pregnancy tests claim to be 99 per cent accurate, although this may not always be the case. For example, a test can be falsely positive for a variety of reasons, including biochemical pregnancy, ectopic pregnancy, or menopause. Although these problems are not common, they can all contribute to misleading test results.

It Detects HCG at Least 50 mIU/ml

The iCARE HCG Rapid Test detects pregnancy when the serum or urine level of HCG reaches a critical threshold. Ideally, the level of hCG should be at least 50 mIU/ml, but there are cases when lower levels of HCG can indicate pregnancy. The test is accurate up to 8 days after the implantation of the egg.

The HCG hormone is produced by trophoblast cells early in pregnancy. Once implantation has taken place, the placenta begins to produce increasing amounts of this hormone. This hormone is a key marker for the implantation process. Pregnant women can use HCG tests to diagnose an early pregnancy and to screen for conditions such as Down syndrome.

It May Show Color Development Over Time

The iCARE HCG Rapid Test is a urine test that detects the presence of human chorionic gonadotropin (HCG). A color band appears when the test shows a positive result. If there is no band, the test is negative. The test strip may show color development over time if the specimen has been properly diluted.

It is a Presumptive Diagnosis for Pregnancy

The iCARE HCG Rapid Test is based on the presence of human chorionic gonadoteophin (HCG), a hormone that begins to be produced in the developing placenta shortly after fertilization. This hormone simulates the production of the pregnancy hormones progesterone and oestrogen. The high levels of HCG can be a sign of pregnancy, and this test can detect the presence of the hormone in urine or blood.

If you are thinking about getting a menopause test, you may be wondering how safe and accurate it is. Fortunately, the iCARE Menopause Test is safe and CLIA-certified. Taking the test can be a great way to confirm your symptoms and to find out if you’re close to menopause.

iCARE Menopause Test is CLIA Certified

CLIA certification of clinical laboratories is a requirement for Medicare payments. However, CLIA certification does not imply that these laboratories must be accredited or have any responsibilities related to the Medicare program. To learn more, read the frequently asked questions (FAQ) document in our Downloads section.

Menopause is a natural process that occurs when a woman’s menstrual cycles cease for 12 months. During this period, a woman cannot conceive. This natural transition usually happens gradually between the ages of 45 and 55, but can be triggered earlier by certain health conditions or medical procedures.

iCARE Menopause Test

The iCARE menopause test can provide a quick result. Results can be available within a few days. This test may require a saliva or blood sample. This is not the preferred option for some women, who have a fear of needles. The results of this test can be shared with a doctor, if necessary. The test is suitable for perimenopausal women experiencing menopause symptoms. You will receive a collection tube, biohazard bag, and pre-paid envelope to send the sample.

You can also try the iCARE menopause test at home. The test will tell you the levels of three hormones. The results will be posted online within two to five days. You will also have access to a dedicated team of nurses to answer any questions you have about your results. The cost of a menopause test can range from less than $10 to nearly $200. You should choose the test that will best suit your budget. Consider factors such as how the sample is collected, which hormones will be measured, and how long you can wait for results.

iCARE Menopause Test is Safe

The iCARE menopause test is a safe and convenient way to determine whether a woman is approaching menopause. It measures the level of luteinizing hormone in a woman’s urine. The results can be shared with a doctor. It is recommended for peri and post-menopausal women, as well as women who have menopause symptoms and want to determine their fertility status. The test kit includes a saliva collection tube, biohazard bags, and a pre-paid envelope.

The iCARE menopause test is safe to use and can give immediate results. However, the test does require a sample of your saliva or blood, which may not be comfortable for some women. Moreover, some people have a fear of needles. Those who are unsure about the test should consult with a physician before proceeding. This way, the doctor can assess the symptoms you’re experiencing and ask about your family history.

iCARE Menopause Test Results

If you’re unsure of whether you’ve reached menopause or not, a menopause test from iCARE can help you. Some tests have results that can be read in a matter of days, while others require a blood or saliva sample. This can be scary for some women who are afraid of needles. Regardless of which test you choose, it is important to see a doctor for a proper diagnosis.

A menopause test measures certain hormones in your body. These hormones control your menstrual cycle and help develop eggs. They increase in a woman’s body each month, which can be an indication of menopause. Menopause symptoms can also be signs of thyroid disease or other medical problems. A menopause test can help you make the right treatment decision, or make a woman aware of a potential underlying condition that may be affecting her reproductive system.

iCARE Follicle-Stimulation Hormone Test

The iCARE Follicle-Stimulation Hormone Test (FSH) is an affordable and convenient blood test that measures the amount of FSH in your blood. It is an important test that can identify many health conditions, so taking it can save you time and money. This test only requires a morning collection, so you can avoid the hassle of visiting the doctor’s office.